Navigation Links
Synthetic Biology Market by Tool, Technology (Bioinformatics, Nanotechnology, Gene Synthesis, Cloning & Sequencing), Application (Biofuels, Pharmaceuticals, Biomaterials, Bioremediation) - Global Forecast to 2018
Date:12/4/2014

NEW YORK, Dec. 4, 2014 /PRNewswire/ -- The synthetic biology market is rapidly evolving, with various technological advancements that have resulted in a paradigm shift within the market. This has resulted in advanced production of synthetic genes and chassis to develop synthetic organisms from scratch.

In 2013, the oligonucleotides segment accounted for the largest share of the global synthetic biology market, by tool, while enabling technologies accounted for the largest share of the synthetic biology market, by technology. The medical application segment accounted for a major share of the synthetic biology applications market in 2013.

North America accounted for the largest share of the global synthetic biology market, followed by Europe, Asia, and the Rest of the World (RoW). In the coming years, Europe is expected to witness the highest growth rate, with emphasis on Germany, U.K., France, Denmark, Switzerland, and Rest of Europe. These countries are expected to serve as revenue pockets for synthetic biology manufacturers.

The global synthetic biology market witnesses high-competitive intensity as there are several big and many small firms with similar product offerings. These companies adopt various strategies (new product launches, acquisitions, and geographical expansions) to increase their market shares and to establish a strong foothold in the global market.

Reasons to Buy the Report:

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn helps the firms to garner a greater market share. Firms purchasing the report could use any one or a combination of the below mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:

- Market Penetration: Comprehensive information on the product portfolios offered by the top players in the synthetic biology market. The report analyzes synthetic biology products by tools, technologies, applications, and region

- Product Development/Innovation: Detailed insights on the upcoming technologies, research and development activities, and new product launches in the synthetic biology market

- Market Development: Comprehensive information about the lucrative emerging markets. The report analyzes the markets for various synthetic biology technologies across regions

- Market Diversification: Exhaustive information about new products, untapped regions, recent developments, and investments in the synthetic biology market

- Competitive Assessment: In-depth assessment of the market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the synthetic biology market

Read the full report: http://www.reportlinker.com/p02514947-summary/view-report.html

About Reportlinker
ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - instantly, in one place.

http://www.reportlinker.com


__________________________
Contact Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001

 


'/>"/>
SOURCE Reportlinker
Copyright©2014 PR Newswire.
All rights reserved

Related biology technology :

1. Synthetic Biology Market Expected to Reach $5,630.4 Million in 2018 - New Report by MarketsandMarkets
2. Synthetic Biologics to Report Third Quarter 2014 Financial Results
3. Biotech Equities Movers and Shakers - Organovo Holdings, Medivation, Pharmacyclics, Synthetic Biologics, and Ironwood Pharma
4. Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program
5. Synthetic Biologics to Raise $20.7 Million in Registered Direct Offering
6. Synthetic Biologics Statin-Class Candidate for Constipation-Predominant Irritable Bowel Syndrome Detailed at Companys Investor Day
7. Synthetic Biology Market (Synthetic DNA, Synthetic Genes, Synthetic Cells, XNA, Chassis Organisms, DNA Synthesis, Oligonucleotide Synthesis) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast,2013 - 2019
8. Synthetic Biologics Highlights New Data from C. difficile Program Presented at the 54th ICAAC
9. Synthetic Biologics to Present at the 16th Annual Rodman & Renshaw Global Investment Conference in New York City
10. UO-Berkeley Lab unveil new nano-sized synthetic scaffolding technique
11. Synthetic Biologics to Initiate Clinical Trials of SYN-004 in 4Q 2014 to Prevent Potentially Deadly C. difficile Infections
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/10/2019)... ... April 10, 2019 , ... ... locked into multiple agreements to help companies advance their innovations to clinical ... ranging from synthetic biology companies that are gene editing therapeutic cells for ...
(Date:4/8/2019)... and BOSTON (PRWEB) , ... April 08, 2019 ... ... cloud-based enterprise-class unified communications and collaboration solutions, announced today the launch of their ... to an unprecedented range of business and contact-orientated applications while using CT Cloud ...
(Date:3/29/2019)... ... March 28, 2019 , ... Specific Diagnostics announced today ... with a second stage of funding for Specific’s Reveal™ rapid antibiotic susceptibility test ... of the $1.7 million already awarded by CARB-X. The additional $1.7M will enable ...
(Date:3/23/2019)... ... March 22, 2019 , ... Tosoh Bioscience LLC ... (MALS) detector , offering a revolutionary approach for the measurement of molecular weight ... A novel optical design, a unique cell-block assembly, and a new calculation methodology ...
Breaking Biology Technology:
(Date:3/27/2019)... ... 2019 , ... Evan Holden , a shareholder in the Atlanta ... at the National Academy of Sciences (NAS) Roundtable on Biomedical Engineering Materials Applications (BEMA), ... firm’s award-winning Pharmaceutical, Medical Device & Health Care Litigation Practice , addressed, “Medical ...
(Date:3/26/2019)... ... March 26, 2019 , ... Ms. ... the company’s products and services. In her position, Ms. Wein will also oversee ... the company’s website and customer beneficial features as well as any other marketing ...
(Date:3/25/2019)... ... 2019 , ... Abcam, a global innovator in life science ... discovery, have announced a collaboration to develop new reagents and kits for improved ... get a better view of complex structures such as the brain and nervous ...
Breaking Biology News(10 mins):